These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1650391)

  • 1. [Low molecular weight heparins in everyday practice].
    Horellou MH; Samama M
    J Mal Vasc; 1991; 16(2):179-83. PubMed ID: 1650391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Practical use of low molecular weight heparins in angiology].
    Plettner JL
    J Mal Vasc; 1991; 16(4):398-401. PubMed ID: 1665170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic indications of low molecular weight heparins].
    Samama MM; Michaut-Paterno F
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D; Hirsh J; Heit J; Prins M; Davidson B; Lensing AW
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The new heparins].
    Samama M; Babinet-Berthier A
    J Mal Vasc; 1992; 17(2):91-106. PubMed ID: 1319447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low molecular weight heparins].
    Doutremepuich C; Lalanne MC; Guyot M; Doutremepuich F; Fernandez G; De Seze O; Deharo E; Vairel EG; Quilichini R
    Ann Pharm Fr; 1989; 47(3):109-16. PubMed ID: 2561387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis].
    Daures JP; Schved JF; Momas I; Gril JC; Azoulay P; Gremy F
    Rev Epidemiol Sante Publique; 1989; 37(4):363-9. PubMed ID: 2558404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic and clinical principles for rational anti-thrombotic preventive treatment with low molecular weight heparin].
    Pindur G; Köhler M; Heiden M; Leipnitz C; Rupp KH; Wenzel E
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1149-55. PubMed ID: 1983502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery].
    Grunebaum L; Fricker JP; Wiesel ML; Vergnes Y; Kapps J; Cazenave JP
    J Mal Vasc; 1987; 12 Suppl B():102-4. PubMed ID: 2834478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current indications of low-molecular-weight heparins].
    Vignes S; Meyer G; Marjanovic Z; Farge-Bancel D
    Ann Med Interne (Paris); 1997; 148(2):154-62. PubMed ID: 9238441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of clinical trials of low molecular weight heparin fractions.
    Levine MN; Hirsh J
    Acta Chir Scand Suppl; 1988; 543():73-9. PubMed ID: 2847461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of low molecular weight heparin].
    Maillet P
    Phlebologie; 1992; 45(2):179-83. PubMed ID: 1326773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low molecular weight heparins].
    Agnelli G; Cosmi B
    Medicina (Firenze); 1990; 10(1):9-15. PubMed ID: 2166209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular weight heparins in post-surgical recovery].
    Doutremepuich C; Anne MC; Fernandez G; Pereira F; de Seze O; Doutremepuich F
    Ann Biol Clin (Paris); 1988; 46(3):190-4. PubMed ID: 2841894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparins in patients with renal insufficiency.
    Symes J
    CANNT J; 2008; 18(2):55-61. PubMed ID: 18669012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.